---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-001283"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-08-19T23:59:59+00:00"
generated_at: "2026-05-31T08:40:05.244394+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Renovaro restates Q1 2024 financials due to IPR&D asset impairment error; files lawsuit for fraud

## Summary
- Concluded Q1 2024 financials contained material misstatement in IPR&D asset impairment; assets overstated, net loss understated.
- Error linked to termination of License Agreement for RENB-HV-01, which was deprioritized and terminated by licensor.
- Company will restate Q1 2024 Form 10-Q, expects to file amended report week of Aug 19, 2024.
- Filed suit against Weird Science LLC and others alleging fraudulent concealment of murder-for-hire scheme to induce 2018 merger.
- Seeks equitable relief including return of shares received in merger and damages.

## SEC filing metadata
- accession: 0001731122-24-001283
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-08-19T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 4.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224001283/0001731122-24-001283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224001283/e5891_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-001283
- JSON: https://secwatch.observer/filing/0001731122-24-001283.json
- Plain text: https://secwatch.observer/filing/0001731122-24-001283.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.